Related Articles
Dendritic cell-activated cytokine-induced killer cell-mediated immunotherapy is safe and effective for cancer patients >65 years old
Predictive significance of T cell subset changes during ex vivo generation of adoptive cellular therapy products for the treatment of advanced non‑small cell lung cancer
Influence of autologous dendritic cells on cytokine‑induced killer cell proliferation, cell phenotype and antitumor activity in vitro
Evaluation of 29 indicators for the prognosis of advanced non‑small cell lung cancer with cytokine‑induced killer cell therapy combined with chemotherapy
Suicide gene-modified killer cells as an allogeneic alternative to autologous cytokine-induced killer cell immunotherapy of hepatocellular carcinoma